Related Experiment Video
Updated: Mar 6, 2026
06:00
Optimization of the Epimedii Folium Mutton-Oil Processing Technology and Testing Its Effect on Zebrafish Embryonic Development
Published on: March 17, 2023
924
Anti-inflammatory neolignans from Epimedium pseudowushanese
Huihui Ti1, Ping Wu1, Liangxiong Xu1
1a Key Laboratory of Plant Resources Conservation and Sustainable Utilization , South China Botanical Garden, Chinese Academy of Sciences , Guangzhou , PR China.
Natural Product Research
|March 11, 2017
Summary
A new neolignan from Epimedium pseudowushanese exhibits potent anti-inflammatory effects. Compound 6 significantly inhibited lipopolysaccharide-induced tumor necrosis factor alpha secretion in cell-based assays.
Area of Science:
- Natural Product Chemistry
- Pharmacology
Background:
- Epimedium pseudowushanese is a plant source of bioactive compounds.
- Neolignans are a class of natural products with diverse biological activities.
Purpose of the Study:
- To isolate and characterize new and known neolignans from Epimedium pseudowushanese.
- To evaluate the in vitro anti-inflammatory potential of these isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation via spectroscopic methods (NMR, MS).
- In vitro anti-inflammatory assay using RAW264.7 cells stimulated with lipopolysaccharide (LPS).
Main Results:
- One novel 8-O-4' neolignan and nine known neolignans were identified.
- Compound 6 demonstrated the highest anti-inflammatory activity, inhibiting tumor necrosis factor alpha (TNF-α) secretion by 79% in LPS-induced RAW264.7 cells.
- The other nine compounds showed moderate anti-inflammatory effects.
Conclusions:
- Epimedium pseudowushanese is a valuable source of anti-inflammatory neolignans.
- Compound 6 represents a promising candidate for further investigation as an anti-inflammatory agent.
